Table 1 Statistical analysis and the Chi-square test of clinical-pathological information in high and low risk groups of TCGA
Covariates | Type | Total | High | Low | p Value |
|---|---|---|---|---|---|
Grade | G1 | 55 (14.86%) | 20 (10.81%) | 35 (18.92%) | 0 |
Grade | G2 | 177 (47.84%) | 70 (37.84%) | 107 (57.84%) | Â |
Grade | G3 | 121 (32.7%) | 83 (44.86%) | 38 (20.54%) | Â |
Grade | G4 | 12 (3.24%) | 10 (5.41%) | 2 (1.08%) | Â |
Grade | Unknow | 5 (1.35%) | 2 (1.08%) | 3 (1.62%) | Â |
Stage | Stage I | 171 (46.22%) | 75 (40.54%) | 96 (51.89%) | 0.0332 |
Stage | Stage II | 85 (22.97%) | 47 (25.41%) | 38 (20.54%) | Â |
Stage | Stage III | 85 (22.97%) | 51 (27.57%) | 34 (18.38%) | Â |
Stage | Stage IV | 5 (1.35%) | 1 (0.54%) | 4 (2.16%) | Â |
Stage | Unknow | 24 (6.49%) | 11 (5.95%) | 13 (7.03%) | Â |
M | M0 | 266 (71.89%) | 137 (74.05%) | 129 (69.73%) | 0.5832 |
M | M1 | 4 (1.08%) | 1 (0.54%) | 3 (1.62%) | Â |
M | Unknow | 100 (27.03%) | 47 (25.41%) | 53 (28.65%) | Â |
N | N0 | 252 (68.11%) | 130 (70.27%) | 122 (65.95%) | 0.6704 |
N | N1 | 4 (1.08%) | 3 (1.62%) | 1 (0.54%) | Â |
N | Unknow | 114 (30.81%) | 52 (28.11%) | 62 (33.51%) | Â |
T | T1 | 181 (48.92%) | 79 (42.7%) | 102 (55.14%) | 0.0591 |
T | T2 | 93 (25.14%) | 53 (28.65%) | 40 (21.62%) | Â |
T | T3 | 80 (21.62%) | 44 (23.78%) | 36 (19.46%) | Â |
T | T4 | 13 (3.51%) | 9 (4.86%) | 4 (2.16%) | Â |
T | Unknow | 3 (0.81%) | 0 (0%) | 3 (1.62%) | Â |
Age |  <  = 61 | 192 (51.89%) | 96 (51.89%) | 96 (51.89%) | 1 |
Age |  > 61 | 178 (48.11%) | 89 (48.11%) | 89 (48.11%) |  |
Gender | Female | 121 (32.7%) | 58 (31.35%) | 63 (34.05%) | 0.6576 |
Gender | Male | 249 (67.3%) | 127 (68.65%) | 122 (65.95%) | Â |